Indices of low-grade inflammation in polycystic ovary syndrome

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050 · see citing works

Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association

Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401 · see citing works

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · see citing works

Leptin and the regulation of body weight in mammals

Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405 · see citing works

C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease

Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953 · see citing works

Interleukin-6 and the acute phase response

Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734 · see citing works

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513 · see citing works

C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women

Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292 · see citing works

Men at risk: occupation and male infertility.

Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,219 · see citing works

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692 · see citing works

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

Pickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. J. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,241 · see citing works

Inflammatory Markers and the Risk of Coronary Heart Disease in Men and Women

Pai, J. K., Pischon, T., Ma, J., Manson, J. E., Hankinson, S. E., JOSHIPURA, K. J., Curhan, G. C., Rifai, N., Cannuscio, C. C., Stampfer, M. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040967 · Cited by 1,174 · see citing works

Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis

Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/er.18.6.774 · Cited by 1,167 · see citing works

A Survey of the Polycystic Ovary Syndrome in the Greek Island of Lesbos: Hormonal and Metabolic Profile

Diamanti‐Kandarakis, E., Kouli, C., Bergiele, A. T., Filandra, F. A., Tsianateli, T. C., Spina, G., Zapanti, E. D., & Bartzis, M. I. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6148 · Cited by 1,107 · see citing works

Is Type II diabetes mellitus a disease of the innate immune system?

Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,040 · see citing works

Insulin-Like Growth Factors as Intraovarian Regulators of Granulosa Cell Growth and Function*

Adashi, E. Y., Resnick, C. E., D’Ercole, A. J., SVOBODA, M. E., & Wyk, J. J. V. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-3-400 · Cited by 911 · see citing works

Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome

Fernández-Real, J. M., & Ricart, W. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0010 · Cited by 886 · see citing works

The Insulin-Related Ovarian Regulatory System in Health and Disease

Poretsky, L., Cataldo, N. A., Rosenwaks, Z., & Giudice, L. C. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0374 · Cited by 839 · see citing works

Clustering of metabolic factors and coronary heart disease

Wilson, P. W. F., Kannel, W. B., Silbershatz, H., & D'Agostino, R. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1104 · Cited by 712 · see citing works

Biomarkers of Endothelial Dysfunction and Risk of Type 2 Diabetes Mellitus

Meigs, J. B. (2004) · JAMA · doi:10.1001/jama.291.16.1978 · Cited by 643 · see citing works

Low grade chronic inflammation in women with polycystic ovarian syndrome

Kelly, C. C. J., Lyall, H., Petrie, J. R., Gould, G. W., Connell, J. M. C., & Sattar, N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7580 · Cited by 640 · see citing works

Interleukin-18 Is a Strong Predictor of Cardiovascular Death in Stable and Unstable Angina

Blankenberg, S., Tiret, L., Bickel, C., Peetz, D., Cambien, F., Meyer, J., & Rupprecht, H. J. (2002) · Circulation · doi:10.1161/01.cir.0000020546.30940.92 · Cited by 560 · see citing works

Resistin and obesity-associated insulin resistance

Steppan, C. M., & Lazar, M. A. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00522-7 · Cited by 525 · see citing works

Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome

Talbott, E. O., Guzick, D. S., Clerici, A., Berga, S. L., Detre, K. M., Weimer, K., & Kuller, L. H. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.7.821 · Cited by 499 · see citing works

Lipoprotein Lipid Concentrations and Cardiovascular Risk in Women with Polycystic Ovary Syndrome

Wild, R. A., Painter, P. C., Coulson, P. B., CARRUTH, K. B., & Ranney, G. B. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-5-946 · Cited by 480 · see citing works

Polycystic Ovary Syndrome Is Associated With Endothelial Dysfunction

Paradisi, G., Steinberg, H. O., Hempfling, A., Cronin, J., Brechtel, G., Shepard, M. K., & Baron, A. (2001) · Circulation · doi:10.1161/01.cir.103.10.1410 · Cited by 476 · see citing works

Interleukin-18: A Novel Cytokine That Augments Both Innate and Acquired Immunity

Okamura, H., Tsutsui, H., Kashiwamura, S., Yoshimoto, T., & Nakanishi, K. (1998) · Advances in immunology · doi:10.1016/s0065-2776(08)60389-2 · Cited by 450 · see citing works

Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus

Ovalle, F., & Azziz, R. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03111-4 · Cited by 428 · see citing works

Inflammation and Coronary Artery Disease

Alexander, R. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310709 · Cited by 400 · see citing works

Prevalence and Predictors of Coronary Artery Calcification in Women with Polycystic Ovary Syndrome

Christian, R. C., Dumesic, D. A., Behrenbeck, T. R., Oberg, A. L., Sheedy, P. F., & Fitzpatrick, L. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030334 · Cited by 396 · see citing works

Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries.

Willis, D., Mason, H., Gilling-Smith, C., & Franks, S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550768 · Cited by 371 · see citing works

White Blood Cell Count and Incidence of Coronary Heart Disease and Ischemic Stroke and Mortality from Cardiovascular Disease in African-American and White Men and Women: Atherosclerosis Risk in Communities Study

Lee, C.-D. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.8.758 · Cited by 346 · see citing works

Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)

Dunaif, A., Wu, X., Lee, A., & Diamanti-Kandarakis, E. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.2.e392 · Cited by 337 · see citing works

Insulin-Like Growth Factor I and Insulin Potentiate Luteinizing Hormone-Induced Androgen Synthesis by Rat Ovarian Thecal-Interstitial Cells*

Cara, J. F., & Rosenfield, R. L. (1988) · Endocrinology · doi:10.1210/endo-123-2-733 · Cited by 333 · see citing works

Increased C-Reactive Protein Levels in the Polycystic Ovary Syndrome: A Marker of Cardiovascular Disease

Boulman, N., Levy, Y., Leiba, R., Shachar, S. S., Linn, R., Zinder, O., & Blumenfeld, Z. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031096 · Cited by 332 · see citing works

Pathophysiological implications of insulin resistance on vascular endothelial function

Wheatcroft, S. B., Williams, I. L., Shah, A. M., & Kearney, M. T. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00869.x · Cited by 307 · see citing works

Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease

Fenkçi, V., Fenkçi, S. M., Yılmazer, M., & Serteser, M. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00571-5 · Cited by 306 · see citing works

Polycystic ovary syndrome: Syndrome XX?

Sam, S., & Dunaif, A. E. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2003.08.002 · Cited by 302 · see citing works

Endothelial Dysfunction in Young Women with Polycystic Ovary Syndrome: Relationship with Insulin Resistance and Low-Grade Chronic Inflammation

Tarkun, İ., ARSLAN, B., Cantürk, Z., Türemen, E., Şahı̇n, T., & Duman, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0751 · Cited by 297 · see citing works

The Cardiovascular Risk of Young Women with Polycystic Ovary Syndrome: An Observational, Analytical, Prospective Case-Control Study

Orio, F., Palomba, S., Spinelli, L., Cascella, T., Tauchmanovà, L., Zullo, F., Lombardi, G., & Colao, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032049 · Cited by 275 · see citing works

Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin

Diamanti‐Kandarakis, E., Paterakis, T., Alexandraki, K., Piperi, C., Aessopos, A., Katsikis, I., Katsilambros, N. L., Kreatsas, G., & Panidis, D. (2006) · Human Reproduction · doi:10.1093/humrep/del003 · Cited by 258 · see citing works

The Increase of Leukocytes as a New Putative Marker of Low-Grade Chronic Inflammation and Early Cardiovascular Risk in Polycystic Ovary Syndrome

Orio, F., Palomba, S., Cascella, T., Biase, S. D., Manguso, F., Tauchmanovà, L., Nardo, L. G., Labella, D., Savastano, S., Russo, T., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0628 · Cited by 257 · see citing works

Weight loss reduces interleukin-18 levels in obese women

Esposito, K., Pontillo, A., Ciotola, M., Di Palo, C., Grella, E., Nicoletti, G., & Giugliano, D. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8781 · Cited by 254 · see citing works

Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin

Bergh, C., Carlsson, B., Olsson, J., Selleskog, U., & Hillensjø, T. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55675-1 · Cited by 253 · see citing works

VCAM-1 is critical in atherosclerosis

Ley, K. F., & Huo, Y. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13005 · Cited by 246 · see citing works

Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus

Dunaif, A. E. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80057-6 · Cited by 235 · see citing works

Increased Endothelin-1 Levels in Women with Polycystic Ovary Syndrome and the Beneficial Effect of Metformin Therapy

Diamanti‐Kandarakis, E., Spina, G., Kouli, C., & Migdalis, I. N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7904 · Cited by 229 · see citing works

Serum Interleukin-18 Concentrations Are Increased in the Polycystic Ovary Syndrome: Relationship to Insulin Resistance and to Obesity

Escobar-Morreale, H. F., Botella-Carretero, J. I., Villuendas, G., Sancho, J., & Millán, J. L. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031365 · Cited by 199 · see citing works

Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome

González, F., Thusu, K., Abdel-Rahman, E., Prabhala, A., Tomani, M., & Dandona, P. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90100-2 · Cited by 199 · see citing works

Distribution and Characterization of Insulin and Insulin-like Growth Factor I Receptors in Normal Human Ovary*

Poretsky, L., Grigorescu, F., Seibel, M. J., Moses, A. C., & Flier, J. S. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-4-728 · Cited by 183 · see citing works

Soluble E-selectin in cardiovascular disease and its risk factors

Roldán, V., Marín, F. R., Lip, G. Y. H., & Blann, A. D. (2003) · Thrombosis and Haemostasis · doi:10.1160/th02-09-0083 · Cited by 182 · see citing works

The polycystic ovary syndrome per se is not associated with increased chronic inflammation

Möhlig, M., Spranger, J., Osterhoff, M., Ristow, M., Pfeiffer, A. F. H., Schill, T., Schlößer, H. W., Brabant, G. E., & Schöfl, C. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500525 · Cited by 182 · see citing works

Acanthosis nigricans in Obese Women with Hyperandrogenism: Characterization of an Insulin-Resistant State Distinct from the Type A and B Syndromes

Flier, J. S., Eastman, R. C., Minaker, K. L., Matteson, D., & Rowe, J. W. (1985) · Diabetes · doi:10.2337/diab.34.2.101 · Cited by 179 · see citing works

Increased levels of serum advanced glycation end‐products in women with polycystic ovary syndrome

Diamanti‐Kandarakis, E., Piperi, C., Kalofoutis, A., & Creatsas, G. C. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02170.x · Cited by 179 · see citing works

Metformin administration improves endothelial function in women with polycystic ovary syndrome

Diamanti‐Kandarakis, E., Alexandraki, K., Protogerou, A. D., Piperi, C., Papamichael, C. M., Aessopos, A., Lekakis, J., & Mavrikakis, M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01910 · Cited by 179 · see citing works

Somatomedin-C/Insulin-Like Growth Factor I as an Enhancer of Androgen Biosynthesis by Cultured Rat Ovarian Cells*

Hernández, E. R., Resnick, C. E., SVOBODA, M. E., Wyk, J. J. V., Payne, D. W., & Adashi, E. Y. (1988) · Endocrinology · doi:10.1210/endo-122-4-1603 · Cited by 156 · see citing works

Evolving Concepts in the Triad of Atherosclerosis, Inflammation and Thrombosis

Corti, R., Hutter, R., Badimón, J. J., & Fuster, V. (2004) · Journal of Thrombosis and Thrombolysis · doi:10.1023/b:thro.0000036027.39353.70 · Cited by 155 · see citing works

Leukocyte Count Correlates in Middle-aged Adults: The Atherosclerosis Risk in Communities (ARIC) Study

Nieto, F. J., Szklo, M., Folsom, A. R., Rock, R. C., & Mercuri, M. F. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116530 · Cited by 140 · see citing works

Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?

Ukkola, O. H. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470571 · Cited by 123 · see citing works

Cardiovascular Risk In Women With Polycystic Ovary Syndrome

Talbott, E. O., Zborowski, J. V., Sutton-Tyrrell, K., McHugh-Pemu, K. P., & Guzick, D. S. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70189-3 · Cited by 113 · see citing works

Troglitazone Therapy Improves Endothelial Function to Near Normal Levels in Women with Polycystic Ovary Syndrome

Paradisi, G., Steinberg, H. O., Shepard, M. K., Brechtel, G., & Baron, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020386 · Cited by 111 · see citing works

SPECIFIC INSULIN BINDING SITES IN HUMAN OVARY

Poretsky, L., SMITH, D., Seibel, M. J., Pazianos, A. G., Moses, A. C., & Flier, J. S. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-4-809 · Cited by 110 · see citing works

Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells

Kristiansen, S. B., Endoh, A., Casson, P. R., Buster, J. E., & Hornsby, P. J. (1997) · Steroids · doi:10.1016/s0039-128x(96)00223-1 · Cited by 108 · see citing works

Serum resistin levels in women with polycystic ovary syndrome

Panidis, D., Koliakos, G., Kourtis, A., Farmakiotis, D., Mouslech, T., & Rousso, D. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.06.021 · Cited by 103 · see citing works

The Methionine 196 Arginine Polymorphism in Exon 6 of the TNF Receptor 2 Gene (TNFRSF1B) Is Associated with the Polycystic Ovary Syndrome and Hyperandrogenism

Peral, B., Millán, J. L. S., Castello, R., Moghetti, P., & Escobar-Morreale, H. F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8715 · Cited by 99 · see citing works

The Relationship between C-Reactive Protein and Carotid Intima-Media Wall Thickness in Middle-Aged Women with Polycystic Ovary Syndrome

Talbott, E. O., Zborowski, J. V., Boudreaux, M. Y., McHugh-Pemu, K. P., Sutton-Tyrrell, K., & Guzick, D. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032110 · Cited by 98 · see citing works

Insulin and insulin-like growth factor I stimulate the proliferation of human ovarian theca-interstitial cells

Dulęba, A. J., Spaczyński, R., & Olive, D. L. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(97)00473-1 · Cited by 98 · see citing works

Association of Polymorphisms in the Interleukin 6 Receptor Complex with Obesity and Hyperandrogenism

Escobar-Morreale, H. F., Calvo, R. M., Villuendas, G., Sancho, J., & Millán, J. L. S. (2003) · Obesity Research · doi:10.1038/oby.2003.136 · Cited by 97 · see citing works

Evidence for Insulin Resistance in Nonobese Patients with Polycystic Ovarian Disease

Jialal, I., Naiker, P., Reddi, K., Moodley, J., & Joubert, S. M. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-5-1066 · Cited by 91 · see citing works

Effects of inhibin-related peptides and oestradiol on androstenedione and progesterone secretion by bovine theca cells in vitro

Wrathall, J. H. M., & KNIGHT, P. G. (1995) · Journal of Endocrinology · doi:10.1677/joe.0.1450491 · Cited by 90 · see citing works

Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumour necrosis factor-α

Stephens, J. M., Butts, M., & Pekala, P. H. (1992) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0090061 · Cited by 86 · see citing works

The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels

Diamanti‐Kandarakis, E., Palioniko, G., Alexandraki, K., Bergiele, A. T., Koutsouba, T., & Bartzis, M. I. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500793 · Cited by 84 · see citing works

Circulating intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in patients with type 2 diabetes mellitus

Kado, S., & Nagata, N. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00083-2 · Cited by 83 · see citing works

Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome

Tıraş, M. B., Yalcin, R., Noyan, V., Maral, İ., Yıldırım, M., Dörtlemez, Ö., & Daya, S. K. (1999) · Human Reproduction · doi:10.1093/humrep/14.8.1949 · Cited by 66 · see citing works

Circulating E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in men with coronary artery disease assessed by angiography and disturbances of carbohydrate metabolism

Kowalska, I., Strączkowski, M., Szelachowska, M., Kinalska, I., Prokop, J., Bachórzewska-Gajewska, H., & St[ecedil]pien, A. (2002) · Metabolism · doi:10.1053/meta.2002.32802 · Cited by 49 · see citing works

WBC Count, Atherosclerosis and Coronary Risk Factors.

Hasegawa, T., Negishi, T., & Deguchi, M. (2002) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9.219 · Cited by 41 · see citing works

The -597 G->A and -174 G->C Polymorphisms in the Promoter of the IL-6 Gene Are Associated with Hyperandrogenism

Villuendas, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.3.1134 · Cited by 33 · see citing works

TNF- and Hyperandrogenism: A Clinical, Biochemical, and Molecular Genetic Study

Escobar-Morreale, H. F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3761 · Cited by 22 · see citing works

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications

Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · see citing works

Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome

Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020 · see citing works

Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis

Escobar-Morreale, H. F., Luque‐Ramírez, M., & González, F. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.11.036 · Cited by 522 · see citing works

Adipose Tissue Has Aberrant Morphology and Function in PCOS: Enlarged Adipocytes and Low Serum Adiponectin, but Not Circulating Sex Steroids, Are Strongly Associated with Insulin Resistance

Mannerås-Holm, L., Leonhardt, H., Kullberg, J., Jennische, E., Odén, A., Holm, G., Hellström, M., Lönn, L., Olivecrona, G., Stener-Victorin, E., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1290 · Cited by 369 · see citing works

Inter‐related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in <scp>PCOS</scp>

Shorakae, S., Ranasinha, S., Abell, S., Lambert, G., Lambert, E., de Courten, B., & Teede, H. (2018) · Clinical Endocrinology · doi:10.1111/cen.13808 · Cited by 176 · see citing works

Involvement of androgens in ovarian health and disease

Lebbe, M., & Woodruff, T. K. (2013) · Molecular Human Reproduction · doi:10.1093/molehr/gat065 · Cited by 165 · see citing works

Polycystic ovary syndrome, adipose tissue and metabolic syndrome

Delitala, A. P., Capobianco, G., Delitala, G., Cherchi, P. L., & Dessole, S. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4429-2 · Cited by 159 · see citing works

Up-Regulated Expression of WNT5a Increases Inflammation and Oxidative Stress via PI3K/AKT/NF-κB Signaling in the Granulosa Cells of PCOS Patients

Zhao, Y., Zhang, C., Huang, Y., Yu, Y., Li, R., Li, M., Liu, N., Liu, P., & Qiao, J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2419 · Cited by 154 · see citing works

Metabonomics Reveals Plasma Metabolic Changes and Inflammatory Marker in Polycystic Ovary Syndrome Patients

Sun, L., Hu, W., Liu, Q., Hao, Q., Sun, B. H., Zhang, Q., Mao, S., Qiao, J., & Yan, X. (2012) · Journal of Proteome Research · doi:10.1021/pr3000317 · Cited by 153 · see citing works

Disturbed stress responses in women with polycystic ovary syndrome

Benson, S., Arck, P., Tan, S., Hahn, S., Mann, K., Rifaie, N., Janssen, O. E., Schedlowski, M., & Elsenbruch, S. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.12.001 · Cited by 142 · see citing works

Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome

Tan, B. K., Adya, R., Syed, F., Chen, J., Lehnert, H., & Randeva, H. S. (2010) · Diabetes · doi:10.2337/db10-0124 · Cited by 138 · see citing works

Enhanced Inflammatory Transcriptome in the Granulosa Cells of Women With Polycystic Ovarian Syndrome

Adams, J. E., Liu, Z., Ren, Y. A., Wun, W.-S. A., Zhou, W. J., Kenigsberg, S., Librach, C. L., Valdés, C. T., Gibbons, W. E., & Richards, J. S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4275 · Cited by 134 · see citing works

Metformin Treatment Exerts Antiinvasive and Antimetastatic Effects in Human Endometrial Carcinoma Cells

Tan, B. K., Adya, R., Chen, J., Lehnert, H., Cassia, L. J. S., & Randeva, H. S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1803 · Cited by 129 · see citing works

Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers

Brenjian, S., Moini, A., Yamini, N., Kashani, L., Faridmojtahedi, M., Bahramrezaie, M., Khodarahmian, M., & Amidi, F. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13186 · Cited by 128 · see citing works

The Effects of Vitamin D Supplementation on Biomarkers of Inflammation and Oxidative Stress Among Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Akbari, M., Ostadmohammadi, V., Lankarani, K. B., Tabrizi, R., Kolahdooz, F., Heydari, S. T., Kavari, S. H., Mirhosseini, N. Z., Mafi, A., Dastorani, M., et al. (2018) · Hormone and Metabolic Research · doi:10.1055/s-0044-101355 · Cited by 122 · see citing works

The effects of old, new and emerging medicines on metabolic aberrations in PCOS

Bargiota, Α., & Diamanti‐Kandarakis, E. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812437355 · Cited by 118 · see citing works

Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review

Lorenzo, M. D., Cacciapuoti, N., Lonardo, M. S., Nasti, G., Gautiero, C., Belfiore, A., Guida, B., & Chiurazzi, M. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00479-8 · Cited by 129 · see citing works

Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies

Behboudi‐Gandevani, S., Tehrani, F. R., Dovom, M. R., Farahmand, M., Khomami, M. B., Noroozzadeh, M., Kabir, A., & Azizi, F. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1117069 · Cited by 113 · see citing works

The impact of high‐intensity interval training on inflammatory markers in metabolic disorders: A meta‐analysis

Khalafi, M., & Symonds, M. E. (2020) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13754 · Cited by 105 · see citing works

Bisphenol A in polycystic ovary syndrome and its association with liver–spleen axis

Tarantino, G., Valentino, R., Somma, C. D., D’Esposito, V., Passaretti, F., Pizza, G., Brancato, V., Orio, F., Formisano, P., Colao, A., et al. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04500.x · Cited by 105 · see citing works

A Lower-Carbohydrate, Higher-Fat Diet Reduces Abdominal and Intermuscular Fat and Increases Insulin Sensitivity in Adults at Risk of Type 2 Diabetes

Gower, B. A., & Goss, A. M. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.195065 · Cited by 98 · see citing works

Polycystic Ovary Syndrome in the Pediatric Population

Bremer, A. A. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0039 · Cited by 96 · see citing works

Coagulation and Fibrinolytic Disturbances in Women with Polycystic Ovary Syndrome

Mannerås-Holm, L., Baghaei, F., Holm, G., Janson, P. O., Ohlsson, C., Lönn, M., & Stener‐Victorin, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2279 · Cited by 93 · see citing works

Role of Androgen Excess on Metabolic Aberrations and Cardiovascular Risk in Women with Polycystic Ovary Syndrome

Christakou, C. D., & Diamanti‐Kandarakis, E. (2008) · Women s Health · doi:10.2217/17455057.4.6.583 · Cited by 90 · see citing works

Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial

Phelan, N., O’Connor, A., Kyaw Tun, T., Correia, N., Boran, G., Roche, H. M., & Gibney, J. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005538 · Cited by 89 · see citing works

NAD+ deficiency and mitochondrial dysfunction in granulosa cells of women with polycystic ovary syndrome‡

Wang, Y., Yang, Q., Wang, H., Zhu, J., Cong, L., Li, H., & Sun, Y. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab078 · Cited by 78 · see citing works

Metformin Increases the Novel Adipokine Cartonectin/CTRP3 in Women With Polycystic Ovary Syndrome

Tan, B. K., Chen, J., Hu, J., Amar, O., Mattu, H. S., Adya, R., Patel, V. C., Ramanjaneya, M., Lehnert, H., & Randeva, H. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2227 · Cited by 72 · see citing works

Effect of metformin on serum interleukin-6 levels in polycystic ovary syndrome: a systematic review

Xu, X., Du, C., Zheng, Q., Peng, L., & Sun, Y. (2014) · BMC Women s Health · doi:10.1186/1472-6874-14-93 · Cited by 67 · see citing works

Metabolic syndrome and polycystic ovary syndrome... and vice versa

Kandaraki, E., Christakou, C. D., & Diamanti‐Kandarakis, E. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200014 · Cited by 67 · see citing works

Adipose expression of adipocytokines in women with polycystic ovary syndrome

Svendsen, P. F., Christiansen, M., Hedley, P. L., Nilas, L., Pedersen, S. B., & Madsbad, S. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.03.056 · Cited by 67 · see citing works

Elevated Levels of Follicular Fatty Acids Induce Ovarian Inflammation via ERK1/2 and Inflammasome Activation in PCOS

Lai, Y.-C., Ye, Z., Mu, L., Zhang, Y., Long, X., Zhang, C., Li, R., Zhao, Y., & Qiao, J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac281 · Cited by 64 · see citing works

Food and Western Disease Health and Nutrition from an Evolutionary Perspective

Lindeberg, S. (2009) · Cited by 64 · see citing works

Current and experimental drug therapy for the treatment of polycystic ovarian syndrome

Corte, L. D., Foreste, V., Barra, F., Gustavino, C., Alessandri, F., Centurioni, M. G., Ferrero, S., Bifulco, G., & Giampaolino, P. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1781815 · Cited by 58 · see citing works

Evaluation of the Pro-inflammatory Cytokine Tumor Necrosis Factor-α in Adolescents with Polycystic Ovary Syndrome

Pawelczak, M., Rosenthal, J. A., Milla, S. S., Liu, Y., & Shah, B. C. (2014) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2014.01.104 · Cited by 52 · see citing works

No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controls

Lindholm, A., Blomquist, C. H., Bixo, M., Dahlbom, I., Hansson, T., Poromaa, I. S., & Burén, J. (2011) · Human Reproduction · doi:10.1093/humrep/der096 · Cited by 52 · see citing works

In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls

Economou, F., Xyrafis, X., Livadas, S., Androulakis, I. I., Argyrakopoulou, G., Christakou, C. D., Kandaraki, E., Palioura, E., & Diamanti‐Kandarakis, E. (2009) · HORMONES · doi:10.14310/horm.2002.1236 · Cited by 51 · see citing works

The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrom patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function

Arikan, S., Akay, H., Bahceci, M., Tuzcu, A., & Gokalp, D. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.057 · Cited by 49 · see citing works

Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction

Pepene, C. E., Ilie, I. R. P., Marian, I., & Duncea, I. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0720 · Cited by 49 · see citing works

The role of stress in PCOS

Papalou, O., & Diamanti-Kandarakis, E. (2017) · Expert Review of Endocrinology &amp; Metabolism · doi:10.1080/17446651.2017.1266250 · Cited by 47 · see citing works

Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping

Caserta, D., Adducchio, G., Picchia, S., Ralli, E., Matteucci, E., & Moscarini, M. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.887673 · Cited by 43 · see citing works

C1QTNF6 participates in the pathogenesis of PCOS by affecting the inflammatory response of granulosa cells

Yan, S., Ding, J., Zhang, Y., Wang, J., Zhang, S., Yin, T., & Yang, J. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab094 · Cited by 42 · see citing works

Interleukin-6 as an Early Chronic Inflammatory Marker in Polycystic Ovary Syndrome with Insulin Receptor Substrate-2 Polymorphism

Lin, Y.-S., Tsai, S., Lin, M., Yang, C., Huang, M., & Wu, M. (2011) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2011.01059.x · Cited by 42 · see citing works

White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia

Papalou, O., Livadas, S., Karachalios, A., Tolia, N., Kokkoris, P., Tripolitakis, K., & Diamanti‐Kandarakis, E. (2014) · HORMONES · doi:10.14310/horm.2002.1563 · Cited by 42 · see citing works

Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome

Androulakis, I., Kandaraki, E., Christakou, C., Karachalios, A., Marinakis, E., Paterakis, T., & Diamanti-Kandarakis, E. (2014) · Clinical Endocrinology · doi:10.1111/cen.12447 · Cited by 46 · see citing works

Association of measures of central fat accumulation indices with body fat distribution and metabolic, hormonal, and inflammatory parameters in women with polycystic ovary syndrome

Ribeiro, V. B., Kogure, G. S., Lopes, I. P., Silva, R. C., Pedroso, D. C. C., Ferriani, R. A., Furtado, C. L. M., & dos Reis, R. M. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000157 · Cited by 39 · see citing works

Uterine Function: From Normal to Polycystic Ovarian Syndrome Alterations

Ferreira, S. R., & Motta, A. B. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867325666171205144119 · Cited by 36 · see citing works

Obesity and inflammatory biomarkers in women with polycystic ovary syndrome

Shen, S.-H., Shen, S.-Y., Liou, T., Hsu, M.-I., Chang, Y. I., Cheng, C.-Y., Hsu, C.-S., & Tzeng, C. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.06.022 · Cited by 35 · see citing works

Metformin increases the novel adipokine adipolin/CTRP12: role of the AMPK pathway

Tan, B. K., Chen, J., Adya, R., Ramanjaneya, M., Patel, V. C., & Randeva, H. S. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0277 · Cited by 33 · see citing works

Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome

Eken, M. K., Ersoy, G. Ş., Abide, Ç. Y., Şanverdi, İ., Devranoğlu, B., Kutlu, T., & Çevik, Ö. D. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2019.1581754 · Cited by 32 · see citing works

Cardiometabolic Risks in Polycystic Ovary Syndrome: Non-Traditional Risk Factors and the Impact of Obesity

Chiu, W.-L., Boyle, J. A., Vincent, A. J., Teede, H. J., & Moran, L. (2016) · Neuroendocrinology · doi:10.1159/000455233 · Cited by 31 · see citing works

Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome (PCOS)

Giallauria, F., Palomba, S., de Sio, I., Maresca, L., Vuolo, L., Savastano, S., Lombardi, G., Colao, A., Vigorito, C., & Orio, F. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03336.x · Cited by 31 · see citing works

Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress‐apoptosis gene expression in PBMCs of women with PCOS

Jabarpour, M., Amidi, F., Aleyasin, A., Nashtaei, M. S., & Saedi-Marghmaleki, M. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18464 · Cited by 31 · see citing works

Serum visfatin levels in non-obese women with polycystic ovary syndrome and matched controls

Kim, J., Choi, Y. M., Hong, M. A., Kim, M.-J., Chae, S. J., Kim, S. M., Hwang, K. R., Yoon, S. H., Ku, S., Suh, C. S., et al. (2018) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2018.61.2.253 · Cited by 26 · see citing works

Plasma levels of pentraxin-3, an inflammatory protein involved in fertility, are reduced in women with polycystic ovary syndrome

Tosi, F., Sarra, D. D., Bonin, C., Zambotti, F., Dall'Alda, M., Fiers, T., Kaufman, J., Donati, M., Franchi, M. P., Zanolin, M. E., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0761 · Cited by 26 · see citing works

New insights into the ovulatory process in the human ovary

Jo, M., Brännström, M., Akins, J. W., & Curry, T. E. (2024) · Human Reproduction Update · doi:10.1093/humupd/dmae027 · Cited by 25 · see citing works

The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus

Rojas, J., Chávez-Castillo, M., & Bermúdez, V. (2014) · International Journal of Reproductive Medicine · doi:10.1155/2014/797681 · Cited by 26 · see citing works

Successful Treatment of Hidradenitis Suppurativa with Infliximab in a Patient Who Failed to Respond to Etanercept

Poulin, Y. P. (2009) · Journal of Cutaneous Medicine and Surgery · doi:10.2310/7750.2008.08034 · Cited by 25 · see citing works

Interleukin 1 beta (IL-1β) promoter C [−511] T polymorphism but not C [+3953] T polymorphism is associated with polycystic ovary syndrome

Mu, Y., Liu, J., Wang, B., Wen, Q., Wang, J., Yan, J., Zhou, S., Ma, X., & Cao, Y. (2009) · Endocrine · doi:10.1007/s12020-009-9268-x · Cited by 24 · see citing works

High sensitivity C-reactive protein and its relationship with impaired glucose regulation in lean patients with polycystic ovary syndrome

Kim, J. W., Han, J. E., Kim, Y. S., Won, H. J., Yoon, T. K., & Lee, W. S. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.613967 · Cited by 23 · see citing works

Exploring the Pharmacological Mechanism of Quercetin-Resveratrol Combination for Polycystic Ovary Syndrome: A Systematic Pharmacological Strategy-Based Research

Yang, K., Zeng, L., Bao, T., Long, Z., & Jin, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-54408-3 · Cited by 23 · see citing works

The Possible Practical Implication of High CRP Levels in PCOS

Blumenfeld, Z. (2019) · Clinical Medicine Insights Reproductive Health · doi:10.1177/1179558119861936 · Cited by 23 · see citing works

ORIGINAL ARTICLE: Uterine Leiomyoma is Associated with a Polymorphism in the Interleukin 1‐β Gene

Pietrowski, D., Thewes, R., Sator, M. O., Denschlag, D., Keck, C., & Tempfer, C. M. (2009) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2009.00718.x · Cited by 22 · see citing works

Hyperreninemia Characterizing Women with Polycystic Ovary Syndrome Improves after Metformin Therapy

Diamanti‐Kandarakis, E., Economou, F., Livadas, S., Tantalaki, E., Piperi, C., Papavassiliou, A. G., & Panidis, D. (2009) · Kidney & Blood Pressure Research · doi:10.1159/000201791 · Cited by 22 · see citing works

Hemostatic and Fibrinolytic Abnormalities in Polycystic Ovary Syndrome

Zoppini, G., Bonora, E., Moghetti, P., & Targher, G. (2014) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0034-1384512 · Cited by 21 · see citing works

Harnessing Expression Data to Identify Novel Candidate Genes in Polycystic Ovary Syndrome

Jones, M. R., Chua, A. K., Chen, Y. I., Li, X., Krauss, R. M., Rotter, J. I., Legro, R. S., Azziz, R., & Goodarzi, M. O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020120 · Cited by 20 · see citing works

Tissue plasminogen activator and plasminogen activator inhibitor 1 in obese and lean patients with polycystic ovary syndrome

Lindholm, Å., Bixo, M., Eliasson, M., Hudecova, M., Arnadottir, R., Holte, J., & Poromaa, I. S. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.487592 · Cited by 19 · see citing works

Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention

Moran, L., Meyer, C., Hutchison, S. K., Zoungas, S., & Teede, H. J. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345790 · Cited by 19 · see citing works

The anti-atherogenic aspect of metformin treatment in insulin resistant women with the polycystic ovary syndrome: Role of the newly established pro-inflammatory adipokine Acute-phase Serum Amyloid A; evidence of an adipose tissue-monocyte axis

Tan, B. K., Adya, R., Shan, X., Aghilla, M., Lehnert, H., Keay, S. D., & Randeva, H. S. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.08.069 · Cited by 18 · see citing works

Polycystic Ovary Syndrome: Focus on Platelets and Prothrombotic Risk

Dasanu, C. A., Clark, B. A., Ichim, T. E., & Alexandrescu, D. T. (2011) · Southern Medical Journal · doi:10.1097/smj.0b013e31820c0172 · Cited by 17 · see citing works

Role and interactions of annexin A 1 and oestrogens in the manifestation of sexual dimorphisms in cerebral and systemic inflammation

Hughes, E. L., Cover, P. O., Buckingham, J. C., & Gavins, F. N. E. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02146.x · Cited by 17 · see citing works

Obesity, but not polycystic ovary syndrome, affects circulating markers of low-grade inflammation in young women without major cardiovascular risk factors

Barcellos, C. R. G., Rocha, M. P., Hayashida, S. A. Y., Dantas, W. S., Yance, V. D. R. V., & Marcondes, J. A. M. (2015) · HORMONES · doi:10.14310/horm.2002.1584 · Cited by 17 · see citing works

Increased circulating soluble P-selectin in polycystic ovary syndrome

Yıldız, B. O., Bozdağ, G., Harmancı, A., Otegen, U., Boynukalin, K., Vural, Z., Kirazlı, Ş., Haznedaroğlu, İ. C., & Yaralı́, H. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.01.121 · Cited by 16 · see citing works

Soluble adhesion molecules levels in patients with Cushing’s syndrome before and after cure

Ermetici, F., Malavazos, A. E., Corbetta, S., Eller-Vainicher, C., Cannavò, S., Corsi, M. M., & Ambrosi, B. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346381 · Cited by 16 · see citing works

Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome

Mansour, A., Hosseini, S., Larijani, B., & Mohajeri-Tehrani, M. R. (2016) · IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund · doi:10.17179/excli2016-422 · Cited by 15 · see citing works

Association of IL-18 genotype with impaired glucose regulation in Korean women with polycystic ovary syndrome

Kim, J. W., Lee, M. H., Park, J. E., Yoon, T. K., Lee, W. S., & Shim, S. H. (2012) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.12.008 · Cited by 15 · see citing works

Association between Interleukin-32 and Interleukin-17A Single Nucleotide Polymorphisms and Serum Levels with Polycystic Ovary Syndrome

Hesampour, F., Jahromi, B. N., Tahmasebi, F., & Gharesi‐Fard, B. (2019) · Iranian Journal of Allergy Asthma and Immunology · doi:10.18502/ijaai.v18i1.634 · Cited by 14 · see citing works

Is the polycystic ovary syndrome the causative of the increase in inflammatory markers and metabolic risk?

Rey-Roldán, E. B., Lana, M. B. P., Galluzzo, L., Blanco, G., Onetto, C., Straminsky, V., & Nolting, M. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.730581 · Cited by 14 · see citing works

Genetic Variation in the Mcp-1 Gene Promoter Associated with the Risk of Polycystic Ovary Syndrome

Li, L., Ryoo, J. E., Lee, K.-J., Choi, B. C., & Baek, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123045 · Cited by 13 · see citing works

Independent predictors of cardiovascular risk in polycystic ovarian syndrome

Türkçüoğlu, İ., Kafkaslı, A., Meydanlı, M. M., Özyalın, F., & Taşkapan, Ç. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2010.551566 · Cited by 12 · see citing works

IL ‐1 receptor antagonist levels are associated with glucose tolerance in polycystic ovary syndrome

Luotola, K., Piltonen, T., Puurunen, J., & Tapanainen, J. S. (2016) · Clinical Endocrinology · doi:10.1111/cen.13077 · Cited by 12 · see citing works

Impact of Androgen and Dietary Advanced Glycation End Products on Female Rat Liver

Palioura, E., Palimeri, S., Piperi, C., Sakellariou, S., Kandaraki, E., Sergentanis, T. Ν., Levidou, G., Agrogiannis, G. D., Papalois, A. E., Korkolopoulou, P. A., et al. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430400 · Cited by 12 · see citing works

Effects of kefir consumption on gut microbiota and health outcomes in women with polycystic ovary syndrome

Dazıroğlu, M. E. Ç., Tek, N. A., Akdulum, M. F. C., Yılmaz, C., & Yalınay, A. M. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4212 · Cited by 11 · see citing works

Disrupting Interleukin 12 Improves Microvascular Endothelial Function in Type 2 Diabetes Through ER Stress CHOP and Oxidative Stress Mechanisms

Radwan, E., Belmadani, S., & Matrougui, K. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s369488 · Cited by 11 · see citing works

The polycystic ovary syndrome (pcos) status and cardiovascular risk in young women

Ilie, I. R. P., Pepene, C. E., Marian, I., Mocan, T., Hazi, G. M., Dragotoiu, G., Ilie, R., MOCAN, L. C., & Duncea, I. (2010) · Open Medicine · doi:10.2478/s11536-010-0054-1 · Cited by 11 · see citing works

Impaired metabolic effects of metformin in men with early-onset androgenic alopecia

Krysiak, R. G., Kowalcze, K. E., & Okopień, B. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00347-8 · Cited by 11 · see citing works

Vascular abnormalities and low-grade chronic inflammation in women with polycystic ovary syndrome: Relationships with insulin resistance, obesity and hyperandrogenemia

Ilie, I. R. P., Pepene, C. E., Duncea, I., & Ilie, R. (2008) · Open Medicine · doi:10.2478/s11536-008-0044-8 · Cited by 10 · see citing works

Polycystic ovary syndrome and related inflammation in radiomics; relationship with patient outcome

Zheng, C.-Y., Yu, Y., & Bai, X. (2023) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2023.02.013 · Cited by 9 · see citing works

Lack of association between interleukin-1a gene (IL-1a) C (-889) T variant and polycystic ovary syndrome in chinese women

Wang, B., Zhou, S., Wang, J., Liu, J., Ni, F., Liu, C., Yan, J., Mu, Y., Cao, Y., & Ma, X. (2009) · Endocrine · doi:10.1007/s12020-009-9152-8 · Cited by 9 · see citing works

Effect of colchicine on polycystic ovary syndrome: an experimental study

Gözükara, İ., Pınar, N., Özcan, O., Özgür, T., Dokuyucu, R., Kurt, R. K., Kucur, S. K., & Aksoy, A. N. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3933-5 · Cited by 9 · see citing works

Psoriasis and polycystic ovary syndrome: a new link in different phenotypes

Moro, F., Tropea, A., Scarinci, E., Federico, A., SIMONE, C. D., Caldarola, G., Leoncini, E., Boccia, S., Lanzone, A., & Apa, R. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.06.002 · Cited by 9 · see citing works

3 CpG Methylation Biomarkers for the Diagnosis of Polycystic Ovary Syndrome (PCOS) in Blood Samples

Zeng, L., Lu, R., Xie, L., Jiang, X., Chen, Y., Huang, C., Chen, Y., Liu, G., & Sun, W.-X. (2021) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207321666210602170054 · Cited by 8 · see citing works

The effects of insulin sensitizers on the cardiovascular risk factors in women with polycystic ovary syndrome

Kassi, E. N., & Diamanti‐Kandarakis, E. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345663 · Cited by 8 · see citing works

Common Inflammatory Markers in Polycystic Ovary Syndrome (PCOS): A BMI (Body Mass Index)-Matched Case–Control Study

Bhattacharya, S. M., & Basu, A. (2018) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-018-1143-3 · Cited by 8 · see citing works

The Multifaceted Role of Signal Peptide-CUB-EGF Domain-Containing Protein (SCUBE) in Cancer

Kumar, S., Prajapati, K. S., & Gupta, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810577 · Cited by 7 · see citing works

Circulating SCUBE1 levels in women with polycystic ovary syndrome

Erol, O., Elli̇dağ, H. Y., Özel, M. K., Uysal, A., Eren, E., & Yılmaz, N. (2018) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.25826 · Cited by 6 · see citing works

Etanercept Ameliorates Vascular, Endocrine, and Ovarian Changes in a Rat Model of DHEA-Induced Polycystic Ovary Syndrome

Korun, Z. E. U., Göçmez, S. S., Rençber, S. F., Sarıhan, K. K., ERALDEMİR, F. C., & Şahin, D. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01392-9 · Cited by 5 · see citing works

Low-Calorie Sweeteners and Reproductive Health: Evidence and Debates

Atalay, E. Ç., Demirhan, B. E., & Celep, G. S. (2024) · Current Nutrition & Food Science · doi:10.2174/0115734013315621240802055207 · Cited by 5 · see citing works

Evaluation of tumor necrosis factor alpha serum level in obese and lean women with clomiphene citrate resistant polycystic ovary disease

Seyam, E., Hasan, M., Khalifa, E. M., Ramadan, A., & Hefzy, E. M. (2017) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2017.01.008 · Cited by 4 · see citing works

Cardiopulmonary functional capacity and the role of exercise in improving maximal oxygen consumption in women with PCOS.

Lenarcik, A., & Bidzińska−Speichert, B. (2010) · PubMed · Cited by 4 · see citing works

Chronic Low Grade Inflammation in Pathogenesis of PCOS

Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073789 · Cited by 680 · see citing works

POLĠKĠSTĠK OVER SENDROMLU HASTALARDA KRONĠK ĠNFLAMMASYON BELĠRTEÇLERĠ OLAN hS -CRP, sICAM-1, sVCAM-1 VE sE-SELEKTĠN DÜZEYLERĠ CHRONIC INFLAMMATION MARKERS hs-CRP, sICAM-1, sVCAM-1 AND sE-SELECTIN LEVELS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME

Açar, D., Vural, P., & Akgül, C. (2010)

Low grade chronic inflammation in women with polycystic ovarian syndrome

Kelly, C. C. J., Lyall, H., Petrie, J. R., Gould, G. W., Connell, J. M. C., & Sattar, N. (2001) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jcem.86.6.7580 · Cited by 640 · see citing works

Chronic Inflammation in Women with Polycystic Ovarian Syndrome

Üstüner, İ., Sönmezer, M., Atabekoğlu, C. S., Ergün, A., Güllü, S., & Aytaç, R. (2006) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3 · see citing works

Low-grade chronic inflammation is not accompanied by structural arterial injury in polycystic ovary syndrome

Costa, L. O. B. F., dos Santos, M. P., de Oliveira, M., & Viana, A. D. O. R. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.04.005 · Cited by 22 · see citing works